Panion & BF Biotech Inc (1760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Panion & BF Biotech Inc (1760) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$73.31 Million ≈ $2.31 Million USD) by net assets (NT$1.90 Billion ≈ $59.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 1760 market cap for the company's overall valuation and market capitalisation.

Panion & BF Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Panion & BF Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Panion & BF Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panion & BF Biotech Inc ranked by their cash flow conversion efficiency. Explore how high is Panion & BF Biotech Inc's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Lollands Bank CO:LOLB	-0.003x
Sam Young Chem KO:003720	0.149x
Heran Co Ltd TW:5283	0.153x
Entech SE SAS PA:ALESE	0.235x
CI Games SA WAR:CIG	0.095x
Jiangsu Dongzhu Landscape Co SHG:603359	0.017x
CareRx Corp TO:CRRX	0.028x
CYGNUS Metals Ltd AU:CY5	-0.033x

Annual Cash Flow Conversion Efficiency for Panion & BF Biotech Inc (2009–2024)

The table below shows the annual cash flow conversion efficiency of Panion & BF Biotech Inc from 2009 to 2024. View Panion & BF Biotech Inc (1760) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.92 Billion ≈ $60.56 Million	NT$351.19 Million ≈ $11.06 Million	0.183x	+96.80%
2023-12-31	NT$1.91 Billion ≈ $60.21 Million	NT$177.42 Million ≈ $5.59 Million	0.093x	-61.96%
2022-12-31	NT$2.01 Billion ≈ $63.24 Million	NT$489.87 Million ≈ $15.43 Million	0.244x	+17.59%
2021-12-31	NT$1.93 Billion ≈ $60.90 Million	NT$401.23 Million ≈ $12.64 Million	0.208x	+1868.28%
2020-12-31	NT$1.24 Billion ≈ $39.07 Million	NT$-14.55 Million ≈ $-458.56K	-0.012x	-117.54%
2019-12-31	NT$1.36 Billion ≈ $42.83 Million	NT$90.98 Million ≈ $2.87 Million	0.067x	+15.01%
2018-12-31	NT$1.35 Billion ≈ $42.55 Million	NT$78.58 Million ≈ $2.48 Million	0.058x	-57.36%
2017-12-31	NT$835.25 Million ≈ $26.31 Million	NT$113.97 Million ≈ $3.59 Million	0.136x	-37.91%
2016-12-31	NT$806.41 Million ≈ $25.41 Million	NT$177.22 Million ≈ $5.58 Million	0.220x	+192.12%
2015-12-31	NT$775.03 Million ≈ $24.42 Million	NT$58.30 Million ≈ $1.84 Million	0.075x	-29.74%
2014-12-31	NT$710.84 Million ≈ $22.40 Million	NT$76.11 Million ≈ $2.40 Million	0.107x	-18.47%
2013-12-31	NT$656.55 Million ≈ $20.68 Million	NT$86.22 Million ≈ $2.72 Million	0.131x	+825.27%
2012-12-31	NT$278.86 Million ≈ $8.79 Million	NT$3.96 Million ≈ $124.70K	0.014x	+111.67%
2011-12-31	NT$296.98 Million ≈ $9.36 Million	NT$-36.12 Million ≈ $-1.14 Million	-0.122x	-164.01%
2010-12-31	NT$301.62 Million ≈ $9.50 Million	NT$-13.89 Million ≈ $-437.77K	-0.046x	-119.43%
2009-12-31	NT$324.61 Million ≈ $10.23 Million	NT$76.98 Million ≈ $2.43 Million	0.237x	--

About Panion & BF Biotech Inc

TW:1760 Taiwan Biotechnology

Market Cap

$146.95 Million

NT$4.66 Billion TWD

Market Cap Rank

#17833 Global

#916 in Taiwan

Share Price

NT$54.40

Change (1 day)

+1.49%

52-Week Range

NT$53.60 - NT$71.20

All Time High

NT$228.22